Literature DB >> 15764787

Lung transplantation: disease-specific considerations for referral.

Steven D Nathan1.   

Abstract

The timing of the referral and listing of patients for lung transplantation remains a difficult decision. Life expectancy and quality of life with and without transplantation are the pivotal issues that need to be considered by physicians and presented to prospective transplant candidates. The recognition of recent advances in the understanding of the various primary diseases, other potential therapies, and the latest posttransplant statistics are essential for a balanced discussion or decision about lung transplantation. This article provides a review of these and other pertinent issues for patients with various forms of advanced lung disease.

Entities:  

Mesh:

Year:  2005        PMID: 15764787     DOI: 10.1378/chest.127.3.1006

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  7 in total

1.  Transcription factor ets-2 plays an important role in the pathogenesis of pulmonary fibrosis.

Authors:  Christopher P Baran; Sara N Fischer; Gerard J Nuovo; Mohamed N Kabbout; Charles L Hitchcock; Benjamin D Bringardner; Sara McMaken; Christie A Newland; Carmen Z Cantemir-Stone; Gary S Phillips; Michael C Ostrowski; Clay B Marsh
Journal:  Am J Respir Cell Mol Biol       Date:  2011-05-11       Impact factor: 6.914

2.  An Investigation of Pulsatile Flow Past Two Cylinders as a Model of Blood Flow in an Artificial Lung.

Authors:  Yu-Chun Lin; Khalil M Khanafer; Robert H Bartlett; Ronald B Hirschl; Joseph L Bull
Journal:  Int J Heat Mass Transf       Date:  2011-07       Impact factor: 5.584

3.  End-of-life care in a COPD patient awaiting lung transplantation: a case report.

Authors:  Daisy Ja Janssen; Martijn A Spruit; Joan D Does; Jos Mga Schols; Emiel Fm Wouters
Journal:  BMC Palliat Care       Date:  2010-04-28       Impact factor: 3.234

Review 4.  Idiopathic pulmonary fibrosis.

Authors:  Eric B Meltzer; Paul W Noble
Journal:  Orphanet J Rare Dis       Date:  2008-03-26       Impact factor: 4.123

5.  Estimating the Individual Treatment Effect on Survival Time Based on Prior Knowledge and Counterfactual Prediction.

Authors:  Yijie Zhao; Hao Zhou; Jin Gu; Hao Ye
Journal:  Entropy (Basel)       Date:  2022-07-14       Impact factor: 2.738

6.  A functional assessment of patients two years after lung transplantation in Poland.

Authors:  Dariusz T Jastrzębski; Anna Gumola; Jacek Wojarski; Sławomir Żegleń; Marek Ochman; Damian Czyżewski; Dariusz Ziora; Marian Zembala; Jerzy Kozielski
Journal:  Kardiochir Torakochirurgia Pol       Date:  2014-06-29

7.  White donor, younger donor and double lung transplant are associated with better survival in sarcoidosis patients.

Authors:  Oriana Salamo; Shiva Roghaee; Michael D Schweitzer; Alejandro Mantero; Shirin Shafazand; Michael Campos; Mehdi Mirsaeidi
Journal:  Sci Rep       Date:  2018-05-03       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.